Shampoos, vitamins and other promises: What does minoxidil really boost?

    ← back to Minoxidil

    Shampoos, Vitamins and Other Promises: What Does Minoxidil Really Boost?

    Hair loss is a growing concern for many people, which has fueled a market saturated with products that promise to reverse or slow down this process. Between fortifying shampoos, specialized vitamins and miracle serums, one of the few treatments approved by the FDA (US Food and Drug Administration) and by national regulators in Europe is topical minoxidil. But how much can this drug really boost? Can it replace other solutions, or should it be used in conjunction with them? Throughout this article we will explore what science says and separate the evidence from the commercial promises.

    Minoxidil: A drug with a history

    Minoxidil was not born as a hair treatment. Initially, it was developed in the 1970s as an oral vasodilator to treat high blood pressure. However, one side effect caught the attention of researchers: hair growth in different areas of the body. This led to its topical reformulation for the treatment of androgenetic alopecia, also known as male and female pattern baldness.

    Today, topical minoxidil is available in 2% and 5% concentrations. In a 48-week randomized trial in 393 men, 5% minoxidil produced more hair regrowth than 2% or placebo (Olsen et al. 2002). It is thought to prolong the anagen (growth) phase of the hair cycle. But its exact mechanism of action remains unclear, although it is believed to improve vascularization of the hair follicle, increase the size of miniaturized follicles, and activate potassium channels.

    The most commonly used products with minoxidil**

    Minoxidil is marketed under various brands and formulations that vary in presentation and concentration. Among the most recognized are:

    Rogaine (Regaine in Europe): This is the pioneer brand in topical minoxidil and one of the most clinically studied. Available as 5% foam and solution for men, and as 2% solution and a once-daily 5% foam (approved in the US in 2014) for women.

    Kirkland Signature: Known for offering a more affordable alternative to Rogaine, it contains 5% minoxidil in topical solution.

    Many other brands and online services sell minoxidil, sometimes with added ingredients such as caffeine, peptides, biotin or saw palmetto. There is no good evidence that these extras add benefit to minoxidil.

    Minoxidil is found in various forms, but the most commonly used are:

    Topical solution: This is the most common form, available in 2% and 5% concentrations. It is applied directly to the scalp and must be used continuously to maintain its effects.

    Foam: Similar to the solution, but with a lighter texture. Foams are usually made without propylene glycol, which may reduce irritation in people with sensitive scalps.

    Oral minoxidil: It is not approved for hair loss; some dermatologists prescribe it off-label in low doses. The tablet is a blood-pressure medicine whose US label carries a boxed warning for pericardial effusion (fluid around the heart, occasionally progressing to tamponade) and worsening angina. Low-dose use for hair loss needs a prescriber and monitoring (DailyMed, minoxidil tablets).

    Combined shampoos and serums: Many brands include minoxidil in formulas with other ingredients such as caffeine or biotin, although evidence on its effectiveness in these formats is limited.

    Despite the variety of presentations and combinations, the key factor remains consistency in its application and following an appropriate regimen under medical supervision.

    Products that combine minoxidil and biotin available on the market

    Many products add biotin, caffeine or saw palmetto to minoxidil. There is no good evidence the extras add benefit, and evidence that biotin helps hair in people without a deficiency is limited. Minoxidil is not approved for use on the face or beard.

    Biotin can also distort some blood tests. The FDA has received reports of biotin causing falsely low results on troponin, a test used to diagnose heart attacks, and warns that biotin can cause incorrect lab results that may go undetected. Tell your doctor and the lab if you take biotin. Therefore, it is advisable to consult a dermatologist before starting any hair loss treatment.

    Does it work better combined with shampoos or vitamins?

    Hair product brands often combine minoxidil with other active ingredients in shampoos or vitamin supplements, suggesting that this will enhance its effect. However, available research does not support a significant improvement when minoxidil is used in shampoos rather than in its classic solution or foam form.

    Minoxidil solutions and foams are left on the scalp. A shampoo is rinsed off within minutes, so it is likely to deliver less of the drug, and no good trial has shown a minoxidil shampoo works as well as a leave-on product. The FDA has not approved any shampoo with minoxidil to treat hair loss.

    As for vitamins, the situation is different. Nutritional deficiencies, such as a lack of iron, biotin or vitamin D, can contribute to hair loss. However, there is no good evidence that supplements add to the effect of minoxidil in people without a deficiency. In fact, studies have shown that excess of certain vitamins, such as A, can even cause hair loss.

    The myth of the immediate "boost": Is it more noticeable in topical or oral form?

    One of the most widespread misconceptions is that minoxidil produces immediate results or that its effect is cumulative in the short term. In reality, the US over-the-counter label says results may appear at 2 months, and that some men need at least 4 months before seeing results.

    The perception of a "boost" or acceleration in results can vary depending on the form of administration:

    Topical minoxidil: Since it is applied directly, its effect depends on the consistency of its use. Some people notice an initial phase of "shedding" (temporary hair loss) before noticing improvements, which can lead to confusion.

    Oral minoxidil: Some small studies have used low-dose oral minoxidil in people with pattern hair loss or chronic telogen effluvium, but it has not been shown in large trials to work faster than topical minoxidil. A retrospective study of 1,404 patients with no control group reported hypertrichosis in 15.1%, lightheadedness in 1.7%, fluid retention in 1.3% and a fast heart rate in 0.9% (Vañó-Galván et al. 2021); a study of this design cannot show how often the drug causes these effects. It is off-label and carries the tablet's boxed warning, so it needs a prescriber.

    Note: It is important to note that minoxidil does not "revitalise" follicles indefinitely. Continued use is necessary to maintain results, as when it is discontinued, the hair stimulated by the drug falls out again within a period of months.

    Sources

    Olsen, E. A., et al. (2002). A randomized clinical trial of 5% topical minoxidil versus 2% topical minoxidil and placebo in the treatment of androgenetic alopecia in men. Journal of the American Academy of Dermatology, 47(3), 377-385. PMID 12196747.

    Suchonwanit, P., Thammarucha, S., & Leerunyakul, K. (2019). Minoxidil and its use in hair disorders: a review. Drug Design, Development and Therapy, 13, 2777-2786. PMID 31496654.

    Vañó-Galván, S., et al. (2021). Safety of low-dose oral minoxidil for hair loss: A multicenter study of 1404 patients. Journal of the American Academy of Dermatology, 84(6), 1644-1651. PMID 33639244.

    Minoxidil tablets — prescribing information (boxed warning). DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=0b4fc036-9497-442b-b629-c4b386932789

    Kirkland Signature minoxidil topical aerosol 5% (foam) — Drug Facts. DailyMed. https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=90137bb7-f0e3-4c3c-9cfb-d4d5eed13a9c

    U.S. Food and Drug Administration. (2022). Biotin Interference with Troponin Lab Tests - Assays Subject to Biotin Interference. https://www.fda.gov/medical-devices/in-vitro-diagnostics/biotin-interference-troponin-lab-tests-assays-subject-biotin-interference